Despite still being technically illegal, the cannabis industry has continued to grow rapidly in North America, with more and more companies going public. In fact, the number of publicly traded cannabis stocks has grown from around 75 in 2014 to over 350 in 2015.
However, while the sector experienced double-digit gains last year, many cannabis stocks have seen share price drops in 2015. As a result, it’s become difficult for investors to decipher which of the many legal cannabis stocks out there are legitimate and which are penny stock scams.
To help cannabis investors better understand what to look for, the Investing News Network spoke with an expert in the space and put together a brief guide on today’s legal cannabis stocks.

What to look for when investing in legal cannabis stocks

As mentioned, the volume of public cannabis stocks in the market has made it difficult to decide which are worth investing in. That’s partially why many stocks are experiencing share price declines despite having great products, teams and assets.
“The main reason cannabis stocks are down is there are no institutional investors,” Derwin Wallace of Cannabis Investor Webcast explained. “There is really no Wall Street involvement, no banks buying the stocks because of federal regulations.”
In other words, looking for cannabis stocks that have cash on hand is a good start. “Cash is my number one metric. If they don’t have any cash, they can’t grow the business,” said Wallace.
Seems simple, doesn’t it? Unfortunately, it’s not always easy to find even basic company information. Wallace explained that because many cannabis stocks are listed on the OTC, they aren’t required to file with the SEC.
“There is a reason they aren’t filing — it could be that they are hiding something, they don’t want you to see something or that they don’t have the money to pay accountants and whatnot. It is a huge red flag,” he noted.
Another metric Wallace said to look at is the number of outstanding shares a company has. If a cannabis stock has a lot of outstanding shares and no revenue, it means that shareholders have little chance of making any money — even if the company eventually does start turning a profit. Other things to look at when choosing a cannabis stock to invest in are liquidity, how many shares are traded per day and outstanding debt.


Management is also important. “You have to look at who is running the company and if they are credible. If you have a pharmaceutical company with a management team with no members with PhDs or doctorates, it doesn’t make much sense, does it?” he quipped.
Furthemore, it’s key to understand that there is an eclectic mix of companies that fit under the “cannabis stocks” banner, from pharmaceutical companies that conduct research, to producers and dispensaries that sell the product to ancillary businesses, including consulting, biotech, real estate, software and security.
“A lot of people think that when we refer to the cannabis space, we are talking about companies that actually touch the plants, either a grower or a dispensary, but it covers a lot more than that,” Wallace said.
Naturally, it’s safer to look at businesses that don’t actually deal with the plants themselves — everything from growing and harvesting equipment, such as lights and fertilizers, to medical containers. Investing in such quasi-cannabis stocks removes the issue of legality completely.
Here is a list of the cannabis stocks and ancillary stocks that Wallace and Technical420 founder Michael Berger believe are worth looking at.

Legal cannabis stock picks

  • Nemus Biosciences (OTCMKTS:NMUS) — A biopharmaceutical company focused on developing and commercializing new chemical entities from cannabinoids.
  • Med-Cannabis Pharma (OTCBB:MCPI) — A company focused on acquiring medical marijuana dispensaries in the US. Currently has three locations in Oregon, where cannabis is legal.
  • Tweed (TSXV:TWD) — A legal medical marijuana company based in Ontario. Tweed is one of the authorized licensed producers under Health Canada’s Marihuana for Medical Purposes Regulations. It recently merged with Bedrocan, another authorized licensed Canadian producer.
  • OrganiGram (TSXV:CGI) — A medical marijuana delivery service for patients and doctors in Canada; also an authorized licensed producer.
  • Mettrum Health (TSXV:MT) — A Canadian cannabis grower also on Health Canada’s authorized licensed producers list.
  • CannLabs (OTCMKTS:CANL) — Full-service cannabis testing lab for both medical and non-medical-grade cannabis products.
  • Pazoo (OTCMKTS:PZOO) — Medical cannabis testing and certification operation in the US.
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE) — A pharmaceutical company looking to develop next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery for patients with significant medical need.
  • Cannabics Pharmaceuticals (OTCMKTS:CNBX) — A US-based cannabis stock focused on developing advanced cannabinoid-based treatments and therapies.

Ancillary cannabis stock picks

These companies have interests in the cannabis sector, but are not focused primarily on the industry and hold interests elsewhere. That means they are often able to avoid legal issues and can operate anywhere.


  • AeroGrow International (OTCMKTS:AERO) — Creator and manufacturer of Miracle-Gro AeroGardens.
  • GW Pharmaceuticals (LSE:GWP,NASDAQ:GWPH) — British biopharmaceutical company known for its cannabinoid medicine Sativex, used for the treatment of spasticity due to multiple sclerosis.
  • Insys Therapeutics (NASDAQ:INSY) — Specialty pharmaceutical company working to develop cannabinoid medicines, such as its inhaled synthetic pharmaceutical cannabinoid products.
  • Heliospectra (OTCMKTS:HLSPY) — LED lighting systems company that creates LED grow lights for greenhouses, indoor growers and researchers.
  • Cafe Serendipity (OTCMKTS:CAFS) — Creating a unique name and brand for the legal cannabis industry.
  • Ambient Water (OTCBB:AWGI) — Formerly AWG International, this company pioneered atmospheric water generation technology for extracting water from humidity in the air.
  • Abbott Laboratories (NYSE:ABT) — Big pharma company with interests in the cannabis space and pharmaceutical products that contain cannabinoids.
  • Blue Line Protection Group (OTCBB:BLPG) — Security company that offers services to cannabis dispensaries.

 
Securities Disclosure: I, Kristen Moran, hold no direct investment interest in any company mentioned in this article.
Related reading: 
How to Invest in Medical Cannabis
Legalizing Medical Cannabis: A Look at the Laws Surrounding Medical Marijuana

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less